Publication | Closed Access
Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation
80
Citations
19
References
2006
Year
Cell TherapyTransplantationCmv InfectionImmunologyAntiviral TherapyStem Cell TransplantationVirologyAntiviral DrugMedicineCell TransplantationPre-emptive Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1